Articles tagged with Vaccination
A Kaiser Permanente study found that older adults vaccinated against shingles are 42% less likely to develop the disease after undergoing chemotherapy. The vaccine also prevented hospitalizations for shingles among vaccinated patients, highlighting its importance in preventing long-term complications.
The BCG vaccine has a 60-80% protective efficacy against severe forms of tuberculosis in children. Research found that the vaccine is effective against TB infection, with a 19% effectiveness rate among vaccinated children after exposure.
A new C. difficile vaccine has been shown to be 100 percent effective in protecting animal models from the deadly intestinal disease caused by Clostridium difficile. The vaccine protects against bacterial toxins and could prevent deadly complications such as severe diarrhea and bowel perforation.
The study found that the HPV vaccine Cervarix provided 100% protection against HPV-16/18 infections over a period of 9.4 years, with high and sustained levels of IgG antibodies observed. The results suggest that the vaccine offered excellent persistence of protective immunity.
A dedicated website for the MMR vaccine is proposed as a simple yet effective way to boost vaccination rates. The study found that providing parents with online information reduces concerns and is more cost-effective than traditional methods like leaflets or face-to-face consultations.
A website providing information on the measles, mumps and rubella (MMR) vaccine is the most cost-effective way to increase its uptake, with a potential saving of £9.20 per vaccination for the NHS. This method is also more convenient for parents seeking additional information about the vaccine.
A study found that minority women who received HPV vaccination even after becoming sexually active had lower rates of abnormal Pap test results. The study suggests that incomplete HPV vaccination may still offer some protection against cervical cancer and its precursors.
A new vaccine developed by researchers at the University of Iowa reduces lung inflammation caused by dust-mite allergens in both lab and animal tests. The vaccine uses a booster called CpG to alter the body's immune response, producing antibodies that dampen the damaging effects of dust-mites.
Researchers from NYU Langone will present new findings on tau immunotherapy and its potential for treating Alzheimer's disease. The presentations focus on the role of mitochondria and death receptors in amyloid toxicity, which may lead to improved treatment options for patients.
A novel AD vaccine, Plp-Adeno-X-CMV-(Aβ3-10)10-CpG, was administered via nasal mucosal inhalation to AD transgenic mouse models, producing strong T helper 2 humoral immune responses and reducing Aβ1-42-induced cytotoxicity. This approach offers a promising therapeutic strategy for Alzheimer's disease.
A recent study of over 500,000 Danish women found no increased risk of venous thromboembolism following quadrivalent HPV vaccination. The research, published in JAMA, used data from national registers to evaluate the potential link between the vaccine and blood clots.
A survey of 1,000 incoming Grand Valley State University students found that moral or religious beliefs were the primary obstacle to receiving the Human Papillomavirus (HPV) vaccine. The study, led by graduate physician assistant researchers, aimed to understand the influence of media on HPV and vaccine compliance.
Endemic infectious diseases continue to affect millions of individuals in the US, with racial and ethnic minorities disproportionately affected. Emerging vector-borne and zoonotic disease infections are threatening new areas and populations.
Scientists expect progress in developing an effective TB vaccine, with Phase IIa clinical trials underway. The new vaccine aims to activate both killer and helper cells for improved immune response.
A study found that a fifth of UK school age children visiting their doctor with a persistent cough could have whooping cough, even if they have been fully vaccinated. The research suggests that an adolescent booster vaccination is needed to protect against pertussis infection.
Researchers developed a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, reprogramming these intractable cancers. The vaccine, GVAX, consists of irradiated tumor cells modified to recruit immune cells, and boosted activity of molecular mechanisms that inhibit cancer-fighting immune cells.
Pertussis cases are rising globally, with an estimated 50 million cases and 300,000 deaths worldwide. Nurses can educate patients and the public on the importance of follow-up booster vaccinations to maintain immunity. Partnerships between healthcare organizations, schools, and communities can also help increase vaccination rates.
A recent study has identified a molecular pathway that could lead to a safer and more effective strep vaccine. The research discovered the genes responsible for producing a molecule that defines Group A Streptococcus, which causes over 700 million infections worldwide each year.
The combined MMRV vaccine has been associated with slightly higher rates of febrile seizures in young children, but these seizures are typically self-limiting and rarely have long-term effects. Researchers found a slight increase in the relative risk of febrile seizure with the MMRV vaccine compared to the separate MMR+V vaccine.
Researchers are developing a new, freeze-stable tetanus vaccine using lipid nanoparticles and a hollow microneedle system. The delivery device can target specific areas of the skin, increasing vaccine efficacy.
The University of Louisville has received a three-year, $5.5 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to develop new treatments and vaccines for various forms of cancer. Researchers will focus on plant-based pharmaceuticals and vaccines for cervical and colon cancer.
A Pittsburgh Supercomputing Center and Johns Hopkins Bloomberg School of Public Health team used HERMES modeling software to help the Republic of Benin redesign its vaccine delivery system, saving an estimated $500,000 in costs while improving vaccination rates.
A recent study found that rates of infant immunization with pertussis-containing vaccine did not increase during a pertussis epidemic in Washington state. Despite high risk, vaccination rates remained stable before and during the epidemic, suggesting that conventional wisdom about vaccine acceptance may be challenged.
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine. A 10-year study found that this protein elicits a highly effective immune response and works across a wide range of people, making it a promising target for future vaccines.
A recent measles outbreak in the US highlights the need for physicians to be familiar with the deadly disease, particularly in return travelers with fever and rash. The author emphasizes the importance of measles vaccination and vigilance in healthcare facilities to prevent further spread.
A comprehensive genomic analysis of Bordetella pertussis bacteria reveals the impact of vaccination on its spread and diversification. The study shows that vaccination has dramatically reduced rates of infection and loss of life from whooping cough, but strategies used to date have not completely eradicated strains of the bacteria.
Cornell scientists developed the first vaccines that can prevent metritis in dairy cows, reducing incidence by up to 83% and alleviating symptoms. The research could help curb antibiotic resistance and save the US billions annually.
A UNSW-led study found that 80% of 2012 Australian whooping cough cases were caused by pertactin-free strains, which may evade vaccine antibodies. The shift could reduce the vaccine's effectiveness in Australia.
A study found a significant reduction in HPV types 16 and 18 infections among young women in England after the introduction of the HPV vaccination program. The prevalence dropped from 1 in 5 to 1 in 15 among those aged 16-18, with the lowest rates among vaccinated individuals.
Researchers found that small financial incentives increased completion of hepatitis B vaccination among injecting drug users, with 45-49% completing the course compared to 9%. The study suggests offering financial incentives can be achieved in routine clinical practice and improve public health outcomes.
Polymeric vaccine adjuvants in nanoparticles, matrices, or micelles can prompt strong adaptive immune responses. Researchers summarize the benefits and challenges of these polymer systems as adjuvants in vaccines.
A new study by University of Pennsylvania researchers found that strain-specific Lyme disease immunity can last six to nine years. This finding has significant implications for vaccine design, as a single vaccine could potentially cover multiple strains of the disease-causing bacteria, substantially reducing the risk of infection.
A recent study in Human Vaccines & Immunotherapeutics found that two doses of the HPV-16/18 AS04-adjuvanted vaccine Cervarix are non-inferior to three doses, providing similar protection against cervical cancer. The two-dose schedule showed a clinically acceptable safety profile and induced strong antibody responses.
Researchers have developed a new technique using DNA vaccines to stimulate the immune system's response against HIV and Hepatitis C viruses. The technique, which has shown promising results in pre-clinical research, involves delivering a vaccination directly into the skin using a micro-needle device.
The Lancet journals publish a special collection on tuberculosis, highlighting emerging challenges like drug-resistant strains and poor treatment outcomes. New anti-tuberculosis drugs and host-directed therapies are being developed to improve treatment efficacy.
A study found that changing hospital orders increased pertussis immunization rates by 69% among new mothers, providing protection for themselves and their newborns. Implementing a standing order led to the largest increase in vaccinations, raising the rate from zero to 69%.
A recent study published on bmj.com found that the HPV vaccine significantly protects against cervical abnormalities in young women. The research estimated that three doses of the vaccine provided 46% protection against high-grade cervical abnormalities and 34% protection against other cervical abnormalities.
A new study by Mayo Clinic reveals that African-American individuals develop twice the antibody response to the rubella vaccine compared to Caucasians. This finding may enable the creation of vaccines tailored to specific ethnic groups or individuals, offering a more effective approach to immunization.
Research from the University of Kent found that stronger belief in anti-vaccine conspiracy theories is associated with lower intention to vaccinate. This study suggests that anti-vaccine conspiracy theories may present a barrier to vaccine uptake, posing significant consequences for children's health.
Researchers have discovered a novel immunological mechanism that regulates B lymphocytes to fight encapsulated bacteria, clearing the path for more efficient vaccines. This discovery improves our understanding of the immune system's protection against infections.
Researchers developed a vaccine against rodent skin papillomavirus that prevented benign and malignant skin tumors in vaccinated animals. The vaccine worked even when given to already infected animals and suppressed the virus in mice treated with immune-suppressive drugs.
A nationwide study found HPV vaccination significantly reduces risk of cervical atypia and CIN2/3 among Danish girls and women. Vaccination with the quadrivalent HPV vaccine is effective in reducing population-level cervical precursor lesion risk.
Research suggests common infections increase stroke risk in children by six times, but routine vaccinations can help decrease this risk. The study found that childhood vaccinations were associated with a lower stroke risk, particularly for those who received all or most vaccines.
A study found that receiving two doses of the HPV vaccine significantly reduces the risk of genital warts and other STDs. The vaccine's efficacy was seen to decrease after three doses, but it still offers substantial protection against these diseases.
A Swedish register study found that receiving three doses of HPV vaccine significantly reduces the incidence of genital warts compared to two doses. The study, published in JAMA, suggests that a three-dose regimen may be more effective in preventing genital warts than previously thought.
A new study published in Pediatrics reveals that HPV vaccine perceptions do not influence subsequent sexual behaviors in teenage girls and young women. The vast majority of participants maintained safer sex habits after vaccination, regardless of their beliefs about the vaccine's effectiveness.
A new adjuvant, IL-33, enhances the immune response to cancer cells and viruses. The protein is being studied as a potential boost for vaccines against pathogens.
Researchers developed a nasal vaccine formulation that provides protective immunity against West Nile virus in mice after only 2 doses. The vaccine was shown to protect 100% of mice from morbidity and weight loss.
Researchers developed a novel method to study enterovirus structures and functions, allowing for tracking of viruses in cells and tissues. The method involves attaching gold nanoparticles to viruses, enabling studies on structural changes and mechanisms of virus uncoating.
Research published in Neurology suggests that having shingles may increase the risk of having a stroke years later, especially in young adults. People aged 18-40 who had shingles were found to be at a higher risk of stroke, heart attack, or transient ischemic attack compared to those who did not have shingles.
The article discusses the use of unlicensed vaccine Bexsero to combat meningitis outbreaks in the US, as well as new guidelines for BRCA mutation screening in high-risk women. The American College of Physicians also explains how Medicaid expansion will benefit poor citizens and their physicians by increasing access to healthcare.
Researchers found that young natural killer cells play a key role in preventing infectious mononucleosis caused by Epstein-Barr Virus. A potential vaccination is being explored to protect against EBV infection and reduce the risk of developing Hodgkin lymphoma.
A new study reveals the BCG vaccine is highly protective against pulmonary TB globally, including in tropical regions. The key to its effectiveness lies in early vaccination before prior infection, suggesting a crucial role for BCG in controlling TB's major burden and transmission.
Researchers have developed an oral vaccine against Helicobacter pylori using Lactobacillus acidophilus as a delivery vehicle. The vaccine elicits specific antibodies and provides significant protection against gastric infection.
Researchers found that moderate drinking boosted the immune system of rhesus macaques, leading to enhanced responses to vaccines. In contrast, heavy drinkers showed diminished vaccine responses. The study suggests a potential link between moderate alcohol consumption and improved immune function.
A study analyzed how celebrities gain credibility as medical advisors and why the public follows their health advice. The researchers found that people's natural tendency to imitate others (herding) and celebrity endorsements can lead to a perception of trustworthiness, despite the lack of medical expertise.
A phase 2 trial of a personalized vaccine made from patient tumor tissue showed improved survival rates compared to standard care alone. The vaccine, HSPPC-96, triggered an immune response to kill remaining tumor cells after surgery.
The pertactin antigen, crucial to the effectiveness of the whooping cough vaccine, is now absent from more than half of US bacterial isolates. The absence of this antigen has significant implications for public health authorities and highlights the need to monitor circulating bacterial populations.
A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, by wrapping it in a polymer chain. This discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.
A study published in Neurology suggests that a vaccine used to prevent tuberculosis may help prevent multiple sclerosis in people showing early signs of the disease. After six months, vaccinated individuals had fewer brain lesions than those who received a placebo, with 58% not developing MS compared to 30%.